Enabling Technology for Safe Robot-assisted Surgical Micromanipulation
安全机器人辅助手术显微操作的实现技术
基本信息
- 批准号:10366680
- 负责人:
- 金额:$ 44.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-15 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlgorithmsAnimal ModelApoptosisAreaBehaviorBilateralBlindnessBlood coagulationCannulasCannulationsClinicalClinical TreatmentCoagulation ProcessCognitiveDisciplineDiseaseEyeEye MovementsEye diseasesFamily suidaeFatigueFeedbackGoalsGrantHandHemorrhageHumanHybridsInfusion proceduresInjuryManualsMeasuresMicromanipulationMicrosurgeryMotionNatural regenerationNeedlesNeural RetinaNeuronsObstructionOperative Surgical ProceduresOphthalmologyOtolaryngologyPerceptionPerformancePerfusionPersonsPharmaceutical PreparationsPhysiologicalPositioning AttributeProceduresPsyche structurePuncture procedureReadinessReproducibilityResearchRetinaRetinal DiseasesRetinal Vein OcclusionRobotRoboticsSafetyScleraSensorySensory ThresholdsStressStructure of central vein of the retinaSurgeonSystemTactileTechniquesTechnologyTherapeutic AgentsThrombusTimeTissuesTranslationsTremorValidationVeinsVisionVisualizationWorkadaptive learningbaseexperiencein vivoin vivo Modelinnovationinstrumentmachine learning methodmultisensoryneurosurgerynovelpre-clinicalpreventreal time monitoringretina blood vessel structurerobot assistancerobot controlrobotic systemsuccesstheoriestoolvirtual
项目摘要
Project Summary / Abstract
The goal of this grant is to develop enabling technology to address fundamental limitations in microsurgery
with a specific focus on developing coordinated bilateral assistance for the vitreoretinal surgeon. Retinal vein
occlusion (RVO) is the second-most-prevalent vision threatening disease of retinal blood vessels, with no
consistently successful clinical treatments to directly resolve the occlusion. A strategic approach, that is
particularly amenable to robotic assistance, is to cannulate the occluded retinal vein with a micro-cannula and to
inject a clot-dissolving agent. Due to human physiological limitations (tremor, tactile perception, visualization,
stress, cognitive requirements, incomplete sensory information, etc.), as well as retinal fragility and the inability
to regenerate retinal tissue, various robotic systems have been developed that target select aspects of retinal
vein cannulation (RVC). However, even with all present and emerging technological advances, a number of
imminently solvable challenges remain as barriers to consistently successful treatment. We propose a bilateral
robotic system with real-time multisensory feedback that assesses multiple points of instrument contact located
both inside and outside of the eye. Our bilateral system will enhance retina and sclera safety, increase the rate
of RVC success, diminish forces on the cannula and vein, reduce the human mental and physical requirements,
and allow the surgeon enhanced motion precision to enable more advanced surgical procedures benefitted by
bilateral manipulation.
To prove the hypothesis that bilateral robot-assisted retinal cannulation is possible and safe, we propose the
following specific aims: (1) Demonstrate coordinated position/force hybrid control algorithms for enabling real-
time sensorimotor capabilities at sclerotomy for safe bilateral robot-assisted vitreoretinal microsurgery: real-time
sensorimotor capabilities at the sclerotomy will be uniquely used to control the robots through a machine learning
method that adaptively learns a nonlinear mapping from user behavior to sclera-force/position and predicts
unsafe motions; (2) Demonstrate position/force-input control algorithms for enabling real-time sensorimotor
capabilities at the tool-tip for safe bilateral robot-assisted vein cannulation: real-time tool-tip-to-tissue interaction
force sensing and non-linear robot control algorithms based on observing user behavior will be used to control
the tool-tip position and force and to prevent entry into subretinal areas during RVC; (3) Demonstrate and
evaluate bilateral RVC using SHER in animal model in vivo: real-time, position/force hybrid control algorithms
based on dual-point (tool-shaft and tip) information fusion will provide sensorimotor guidance of surgical
maneuvers during RVC. Statistically significant results in vivo, in clinically realistic conditions will demonstrate
the feasibility of our approach. This highly innovative system with expanded coordinated bimanual capabilities
will allow us to further increase the safety and reliability of RVC and move the technology to preclinical readiness.
项目摘要/摘要
这笔赠款的目标是开发使能技术,以解决显微外科手术中的根本限制。
特别侧重于为玻璃体视网膜外科医生开发协调的双边援助。视网膜静脉
视网膜血管阻塞(RVO)是视网膜血管疾病中第二常见的威胁视力的疾病。
临床治疗持续成功,直接解决了咬合问题。一种战略方法,也就是
特别适合机器人辅助的是用微导管插管阻塞的视网膜静脉,并
注射一种溶解血栓的药剂。由于人类生理上的限制(震颤、触觉、视觉、
压力、认知要求、感觉信息不完整等),以及视网膜脆弱和无力
为了再生视网膜组织,已经开发了各种机器人系统,以视网膜的特定方面为目标
静脉插管(RVC)。然而,即使有了所有现在和正在出现的技术进步,一些
迫在眉睫的可解决挑战仍然是持续成功治疗的障碍。我们提出了双边协议
具有实时多传感器反馈的机器人系统,可评估定位的多个仪器接触点
眼睛里面和外面都有。我们的双边系统将增强视网膜和巩膜的安全性,提高
减少对插管和静脉的作用力,减少人类的精神和身体需求,
并允许外科医生增强运动精度,以使更先进的手术程序受益于
双边操纵。
为了证明双边机器人辅助视网膜插管是可能和安全的这一假设,我们提出了
具体目标如下:(1)演示协调位置/力混合控制算法,以实现实时控制
用于安全的双眼机器人辅助玻璃体视网膜显微手术的巩膜切开术的时间感觉运动能力:实时
巩膜切开术中的感觉运动能力将独特地用于通过机器学习来控制机器人
一种自适应地学习从用户行为到巩膜力/位置的非线性映射并预测
不安全的运动;(2)演示启用实时传感器电机的位置/力输入控制算法
用于安全的双边机器人辅助静脉插管的工具尖端的能力:实时的工具尖端到组织的交互
将使用力传感和基于观察用户行为的非线性机器人控制算法来控制
在RVC手术中,刀尖的位置和力,防止进入视网膜下区域;(3)演示和
在活体动物模型中应用SHER评价双侧RVC:实时、位置/力混合控制算法
基于刀轴和刀尖双点(刀轴和刀尖)的信息融合将为外科手术提供感知运动指导。
RVC过程中的机动动作。在活体、临床现实条件下具有统计学意义的结果将证明
我们方法的可行性。这一高度创新的系统具有扩展的协调双工能力
这将使我们能够进一步提高RVC的安全性和可靠性,并将该技术推向临床前准备状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER LOUIS GEHLBACH其他文献
PETER LOUIS GEHLBACH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER LOUIS GEHLBACH', 18)}}的其他基金
Enabling Technology for Safe Robot-assisted Surgical Micromanipulation
安全机器人辅助手术显微操作的实现技术
- 批准号:
10602479 - 财政年份:2017
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8972362 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8712494 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8913976 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8192410 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8487410 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
OCT-Guided Free-Hand Semi-Automated Microsurgical Tool for Enhanced Retinal Surge
OCT 引导徒手半自动显微手术工具,用于增强视网膜电涌
- 批准号:
8303214 - 财政年份:2011
- 资助金额:
$ 44.51万 - 项目类别:
Treatment of Ocular Neovascularization by Inhibitors
抑制剂治疗眼部新生血管
- 批准号:
6518719 - 财政年份:2001
- 资助金额:
$ 44.51万 - 项目类别:
Treatment of Ocular Neovascularization by Inhibitors
抑制剂治疗眼部新生血管
- 批准号:
6878477 - 财政年份:2001
- 资助金额:
$ 44.51万 - 项目类别:
Treatment of Ocular Neovascularization by Inhibitors
抑制剂治疗眼部新生血管
- 批准号:
6318589 - 财政年份:2001
- 资助金额:
$ 44.51万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 44.51万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 44.51万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 44.51万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 44.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists